Lois L. Wright
GlaxoSmithKline (United States) · 61 works · 2,003 citations · h-index 27
Top works
- Human Immunodeficiency Virus
- Inhomogeneous translational diffusion of monoclonal antibodies on phospholipid Langmuir-Blodgett films
- Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors
- Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities
- Novel inhibitors of HIV protease
- Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease
- Role of desolvation energy in the nonfacilitated membrane permeability of dideoxyribose analogs of thymidine.
- Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity
- Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties
- Novel and potent cyclic cyanamide-based cathepsin K inhibitors
- Initial binding of 2‘-deoxynucleoside 5‘-triphosphates to human immunodeficiency virus type 1 reverse transcriptase.
- Exploration of the P1 SAR of aldehyde cathepsin K inhibitors
- Exploration of the P2–P3 SAR of aldehyde cathepsin K inhibitors
- Potent and selective P2–P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1′, P1, and/or P3 substitutions
- Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases
- Design of Potent, Selective, and Orally Bioavailable Inhibitors of Cysteine Protease Cathepsin K
- アルデヒド系カテプシンK阻害剤のP 1 部位SAR探究
- Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease
- Design of small molecule ketoamide-based inhibitors of cathepsin K
- P2–P3 conformationally constrained ketoamide-based inhibitors of cathepsin K